| Target Price | $12.24 |
| Price | $0.16 |
| Potential | |
| Number of Estimates | 3 |
| 3 Analysts have issued a price target Arcadia Biosciences, Inc. 2027 . The average Arcadia Biosciences, Inc. target price is $12.24. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 7 analysts: 6 Analysts recommend Arcadia Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Arcadia Biosciences, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Arcadia Biosciences, Inc. stock at Purchase. |
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
3 Analysts have issued a sales forecast Arcadia Biosciences, Inc. 2026 . The average Arcadia Biosciences, Inc. sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
| 2025 | $4.9m | 3.76% |
|---|---|---|
| 2026 | ||
3 Analysts have issued an Arcadia Biosciences, Inc. EBITDA forecast 2026. The average Arcadia Biosciences, Inc. EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $-3.2m | 56.19% |
|---|---|---|
| 2026 | ||
| 2025 | -66.26% | 54.48% |
|---|---|---|
| 2026 | ||
3 Arcadia Biosciences, Inc. Analysts have issued a net profit forecast 2026. The average Arcadia Biosciences, Inc. net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| 2025 | $-2.3m | 66.76% |
|---|---|---|
| 2026 | ||
| 2025 | -48.15% | 65.46% |
|---|---|---|
| 2026 | ||
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
3 Analysts have issued a Arcadia Biosciences, Inc. forecast for earnings per share. The average Arcadia Biosciences, Inc. EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
| 2025 | $-1.71 | 66.86% |
|---|---|---|
| 2026 | ||
| Current | -0.04 | 93.09% |
|---|---|---|
| 2026 | ||
Arcadia Biosciences, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


